Recombinant Human MAPK3
|Product Overview :||Recombinant Human ERK1/MAPK3 is a highly active form produced by phosphorylation of the purified ERK1/MAPK3 in vitro with MEK1 is a non-glycosylated polypeptide having a molecular mass of 43.6 kDa. ERK1/MAPK3 is purified by proprietary chromatographic techniques. It is producted inEscherichia Coli.|
- Gene Information
- Related Products
|Cat. No. :||MAPK3-34H|
|Description :||Extracellular signal-regulated kinases (ERKs) or classical MAP kinases are widely expressed protein kinase intracellular signaling molecules which are involved in functions including the regulation of meiosis, mitosis, and postmitotic functions in differentiated cells. Many different stimuli, including growth factors, cytokines, virus infection, ligands for heterotrimeric G protein-coupled receptors, transforming agents, and carcinogens, activate the ERK pathway. The term, "extracellular signal-regulated kinases", is sometimes used as a synonym for mitogen-activated protein kinase (MAPK), but has more recently been adopted for a specific subset of the mammalian MAPK family. In the MAPK/ERK pathway, Ras activates c-Raf, followed by MEK and then MAPK1/2 (below).|
|Source :||Escherichia Coli.|
|Physical Appearance :||Sterile Filtered clear solution.|
|Unit Definition :||No protease activity detectable, specific activity > 15.000 U*/mg (*1 U = 1 pmol/min transferred to myelin basic protein at 30 degree C).|
|Purity :||Greater than 95% as determined by SDS-PAGE.|
|Formulation :||ERK1/MAPK3 is supplied as 0.15mg/ml containing 50mM Tris-HCl, 150mM NaCl, 1mM DTT, 50% glycerol, pH 8.5.|
|Stability :||Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. Avoid multiple freeze-thaw cycles.|
|Gene Name :||MAPK3 mitogen-activated protein kinase 3 [ Homo sapiens ]|
|Synonyms :||MAPK3; mitogen-activated protein kinase 3; ERK1; PRKM3; P44ERK1; P44MAPK; HS44KDAP; HUMKER1A; MGC20180;EC18.104.22.168; Extracellular signal-regulated kinase 1; Insulin-stimulated MAP2 kinase; MAP kinase 1; Microtubule-associated protein 2 kinas; OTTHUMP00000174538; OTTHUMP00000174540; Microtubule-associated protein 2 kinase; mitogen-activated protein kinase 3|
|Gene ID :||5595|
|mRNA Refseq :||NM_001040056|
|Protein Refseq :||NP_001035145|
|UniProt ID :||P27361|
|Pathway :||Acute myeloid leukemia; Adherens junction; Alzheimer"s disease; Alzheimer"s disease; B cell receptor signaling pathway; Bladder cancer; Chronic myeloid leukemia; Chemokine signaling pathway; Colorectal cancer; Dorso-ventral axis formation; Endometrial cancer; ErbB signaling pathway; Fc epsilon RI signaling pathway; Fc gamma R-mediated phagocytosis; Gap junction; Glioma; GnRH signaling pathway; Insulin signaling pathway; Long-term potentiation; Long-term depression; MAPK signaling pathway; Melanogenesis; Melanoma; Natural killer cell mediated cytotoxicity; Neurotrophin signaling pathway; Non-small cell lung cancer; Pancreatic cancer; Pathways in cancer; Prion diseases; Regulation of actin cytoskeleton; Renal cell carcinoma; Renal cell carcinoma; T cell receptor signaling pathway; TGF-beta signaling pathway; Thyroid cancer; Toll-like receptor signaling pathway; Type II diabetes mellitus; VEGF signaling pathway; Vascular smooth muscle contraction; mTOR signaling pathway; Axon guidance; Signaling by Insulin receptor; Signaling by EGFR; Signaling by PDGF; Signalling by NGF; Transcription|
|Function :||ATP binding; MAP kinase activity; nucleotide binding; protein binding; protein serine/threonine kinase activity; transferase activity|
|◆ Recombinant Protein|
|MAPK3-1050H||Active Recombinant Human MAPK3 Protein, His/GST-Tagged||+Inquiry|
|MAPK3-1082H||Recombinant Human MAPK3 Protein (A2-P379), Tag Free||+Inquiry|
|MAPK3-307H||Active Recombinant Human MAPK3 Protein||+Inquiry|
|MAPK3-3230R||Recombinant Rat MAPK3 Protein, His (Fc)-Avi-tagged||+Inquiry|
|MAPK3-1083H||Recombinant Human MAPK3 Protein (A2-P379), GST tagged||+Inquiry|
|MAPK3-4494HCL||Recombinant Human MAPK3 293 Cell Lysate||+Inquiry|
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Q&As (7)Ask a question
Dysregulation of MAPK3 signaling has been implicated in the pathogenesis of several diseases. Aberrant activation of MAPK3 is associated with cancer development and progression, as it promotes cell proliferation and survival. MAPK3 signaling is also involved in cardiovascular diseases, contributing to vascular remodeling and hypertrophy. In neurodegenerative diseases, dysregulated MAPK3 activity contributes to neuronal dysfunction and apoptosis.
Future research in MAPK3 aims to elucidate the intricate signaling network and identify novel regulatory mechanisms. Understanding the crosstalk between MAPK3 and other signaling pathways will be crucial for developing targeted therapies. Additionally, exploring the role of MAPK3 isoforms in different cellular contexts and disease states will provide valuable insights. Furthermore, the development of more specific and potent inhibitors with reduced toxicity profiles is a focus for future therapeutic interventions.
MAPK3, also known as ERK1 (Extracellular Signal-Regulated Kinase 1), is a serine/threonine kinase involved in cell signaling pathways. It consists of 379 amino acids and exhibits a conserved catalytic domain. MAPK3 plays a crucial role in regulating cell proliferation, differentiation, and survival by phosphorylating downstream targets such as transcription factors and other kinases.
MAPK3 signaling exerts its effects through phosphorylation of downstream targets. It phosphorylates various transcription factors, including ELK1 and c-Fos, leading to changes in gene expression. MAPK3 also phosphorylates other kinases, such as p90RSK, which further propagate the signal to regulate cellular processes like cell cycle progression, apoptosis, and differentiation.
One challenge is the potential for off-target effects when targeting MAPK3, as it is involved in multiple signaling pathways. Additionally, resistance to MAPK3 inhibitors can emerge due to compensatory signaling mechanisms and genetic alterations. Another challenge lies in achieving selective inhibition of specific MAPK3 isoforms without affecting other closely related kinases.
The activity of MAPK3 is tightly regulated by various mechanisms. Activation of MAPK3 involves dual phosphorylation of threonine and tyrosine residues by upstream kinases. Conversely, dephosphorylation by phosphatases can inactivate MAPK3. Additionally, scaffolding proteins and interacting partners can modulate its activity by facilitating or inhibiting its phosphorylation or by regulating its subcellular localization.
Inhibition of MAPK3 activity or downstream effectors represents a potential therapeutic approach. Small molecule inhibitors targeting MAPK3 kinase activity, such as U0126 and PD98059, have been developed. Monoclonal antibodies against MAPK3 or its downstream effectors are also being investigated. Combination therapies targeting multiple components of the MAPK3 signaling pathway are being explored to enhance efficacy and overcome resistance.
Customer Reviews (3)Write a review
Exemplary precision and unblemished dependability render it my most cherished research ally. -
Presenting exceptional reliability and stability, the experimental reagent establishes a robust foundation for my experiments. -
Exquisitely crafted packaging design adds convenience to the usage of this protein reagent and exudes a sense of sophistication. -
Ask a Question for All MAPK3 Products
Required fields are marked with *
My Review for All MAPK3 Products
Required fields are marked with *